AZ asthma drug cuts oral steroid use
Patients with severe uncontrolled asthma taking AstraZeneca’s experimental drug benralizumab in a late-stage study either significantly reduced or stopped altogether their intake of oral corticosteroids (OCS), while the drug was also shown to dramatically cut related hospitalisations.
Read More
